Anchen Sues Labopharm In Bid To Sell Generic Ryzolt
Anchen Pharmaceuticals Inc. has launched a declaratory judgment suit asserting that its plans to market a generic version of pain reliever Ryzolt does not violate a patent held by Canadian drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article